👀 Ones to watch: Undervalued stocks to buy before they report Q3 earningsSee Undervalued Stocks

CVC to buy Finnish healthcare group Mehilainen from KKR, Triton

Published 18/05/2018, 08:19
© Reuters.  CVC to buy Finnish healthcare group Mehilainen from KKR, Triton
KKR
-
ATTE
-
TTALO
-

HELSINKI (Reuters) - Buyout fund CVC Capital has agreed to buy a majority stake in Mehilainen, one of Finland's largest healthcare companies, from private equity companies KKR (N:KKR) and Triton.

The companies, announcing the sale in separate statements on Friday, did not disclose the price but the Financial Times, citing unnamed sources, said the deal would be valued at 1.8 billion euros (1.5 billion pounds). Mehilainen had sales of 756 million euros last year.

The Finnish healthcare industry is restructuring ahead of a potential shake-up aimed at boosting competition between healthcare providers by opening up more opportunities to the private sector.

Mehilainen said CVC would buy a stake of around 50 percent and Finnish insurance group Lahitapiola and pension funds Varma and Ilmarinen would increase their stakes to more than 30 percent combined. The actual stakes will be announced when the deal has closed.

"This is a very good solution. A stock market listing would have been an option, but this is better at this stage as the market is in transformation," Mehilainen's CEO Janne-Olli Jarvenpaa told Reuters by phone. "We'll have a long-term investor with capability to fund growth projects."

He declined to disclose the price of the deal and CVC, KKR and Triton were not immediately available to comment.

The Finnish parliament is expected to vote on the government's healthcare reform bill next month.

On Thursday, Mehilainen's rival Terveystalo (HE:TTALO) agreed to buy Swedish rival Attendo's (ST:ATTE) Finnish operations for 233 million euros.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.